The presentation focused on:
Most on-site audits of excipient suppliers have been suspended (deferred) due to the pandemic; however, on-going supplier assessments are still required.
Although it would be difficult, if not impossible, to perform a remote (virtual) audit to assess a new supplier/customer, a remote audit may be an acceptable alternative for a surveillance audit.
Recognizing the challenges that these remote audits bring; how can an auditor accomplish their objective to adequately evaluate (assess) a site? How can the auditee maximize the effectiveness of this approach? This webinar will offer suggestions to achieve these mutual objectives.